79 related articles for article (PubMed ID: 29254787)
21. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
Lian F; Cui Y; Zhou C; Gao K; Wu L
PLoS One; 2015; 10(3):e0121499. PubMed ID: 25775010
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-539 suppresses osteosarcoma cell invasion and migration in vitro and targeting Matrix metallopeptidase-8.
Jin H; Wang W
Int J Clin Exp Pathol; 2015; 8(7):8075-82. PubMed ID: 26339374
[TBL] [Abstract][Full Text] [Related]
23. MiR-223/Ect2/p21 signaling regulates osteosarcoma cell cycle progression and proliferation.
Xu J; Yao Q; Hou Y; Xu M; Liu S; Yang L; Zhang L; Xu H
Biomed Pharmacother; 2013 Jun; 67(5):381-6. PubMed ID: 23601845
[TBL] [Abstract][Full Text] [Related]
24. miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control.
Novello C; Pazzaglia L; Cingolani C; Conti A; Quattrini I; Manara MC; Tognon M; Picci P; Benassi MS
Int J Oncol; 2013 Feb; 42(2):667-75. PubMed ID: 23229283
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-375 functions as a tumor suppressor in osteosarcoma by targeting PIK3CA.
Shi ZC; Chu XR; Wu YG; Wu JH; Lu CW; Lü RX; Ding MC; Mao NF
Tumour Biol; 2015 Nov; 36(11):8579-84. PubMed ID: 26036761
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X
Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
[TBL] [Abstract][Full Text] [Related]
27. Demethylation-mediated miR-129-5p up-regulation inhibits malignant phenotype of osteogenic osteosarcoma by targeting Homo sapiens valosin-containing protein (VCP).
Long XH; Zhou YF; Peng AF; Zhang ZH; Chen XY; Chen WZ; Liu JM; Huang SH; Liu ZL
Tumour Biol; 2015 May; 36(5):3799-806. PubMed ID: 25566966
[TBL] [Abstract][Full Text] [Related]
28. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
Piperigkou Z; Franchi M; Götte M; Karamanos NK
Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
[TBL] [Abstract][Full Text] [Related]
29. MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR.
Liu Y; Zhu ST; Wang X; Deng J; Li WH; Zhang P; Liu BS
Technol Cancer Res Treat; 2016 Oct; 15(5):NP40-8. PubMed ID: 26306402
[TBL] [Abstract][Full Text] [Related]
30. miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer.
Xu C; Li S; Chen T; Hu H; Ding C; Xu Z; Chen J; Liu Z; Lei Z; Zhang HT; Li C; Zhao J
Oncol Rep; 2016 Jan; 35(1):497-503. PubMed ID: 26549165
[TBL] [Abstract][Full Text] [Related]
31. MiR-509-3-5p causes aberrant mitosis and anti-proliferative effect by suppression of PLK1 in human lung cancer A549 cells.
Wang XH; Lu Y; Liang JJ; Cao JX; Jin YQ; An GS; Ni JH; Jia HT; Li SY
Biochem Biophys Res Commun; 2016 Sep; 478(2):676-82. PubMed ID: 27498003
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-1 functions as a potential tumor suppressor in osteosarcoma by targeting Med1 and Med31.
Jiang C; Chen H; Shao L; Wang Q
Oncol Rep; 2014 Sep; 32(3):1249-56. PubMed ID: 24969180
[TBL] [Abstract][Full Text] [Related]
33. MiR-125b Functions as a Tumor Suppressor and Enhances Chemosensitivity to Cisplatin in Osteosarcoma.
Wang F; Yu D; Liu Z; Wang R; Xu Y; Cui H; Zhao T
Technol Cancer Res Treat; 2016 Dec; 15(6):NP105-NP112. PubMed ID: 26744308
[TBL] [Abstract][Full Text] [Related]
34. Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway.
Liu Q; Yang G; Qian Y
Mol Carcinog; 2017 Apr; 56(4):1312-1321. PubMed ID: 27859625
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
[TBL] [Abstract][Full Text] [Related]
36. MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients.
Zhang F; Huang W; Sheng M; Liu T
Tumour Biol; 2015 Mar; 36(3):2041-8. PubMed ID: 25391425
[TBL] [Abstract][Full Text] [Related]
37. miR-27a-3p promotes the malignant phenotypes of osteosarcoma by targeting ten-eleven translocation 1.
Liu J; Li M; Liu X; Liu F; Zhu J
Int J Oncol; 2018 Apr; 52(4):1295-1304. PubMed ID: 29484426
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-101 inhibits the metastasis of osteosarcoma cells by downregulation of EZH2 expression.
Zhang K; Zhang Y; Ren K; Zhao G; Yan K; Ma B
Oncol Rep; 2014 Nov; 32(5):2143-9. PubMed ID: 25190211
[TBL] [Abstract][Full Text] [Related]
39. Epigenetically altered miR-1247 functions as a tumor suppressor in pancreatic cancer.
Yi JM; Kang EJ; Kwon HM; Bae JH; Kang K; Ahuja N; Yang K
Oncotarget; 2017 Apr; 8(16):26600-26612. PubMed ID: 28460450
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of miR-10b in colorectal cancer patients: Correlation with TWIST-1 and E-cadherin expression.
Abdelmaksoud-Dammak R; Chamtouri N; Triki M; Saadallah-Kallel A; Ayadi W; Charfi S; Khabir A; Ayadi L; Sallemi-Boudawara T; Mokdad-Gargouri R
Tumour Biol; 2017 Mar; 39(3):1010428317695916. PubMed ID: 28345456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
